Zyhcg: Advanced Hormone Therapy for Precision Endocrine Care
ZyhCG
| Product dosage: 5000iu | |||
|---|---|---|---|
| Package (num) | Per injection | Price | Buy |
| 1 | $50.00 | $50.00 (0%) | 🛒 Add to cart |
| 2 | $45.00 | $100.00 $90.00 (10%) | 🛒 Add to cart |
| 3 | $43.33 | $150.00 $130.00 (13%) | 🛒 Add to cart |
| 4 | $42.00 | $200.00 $168.00 (16%) | 🛒 Add to cart |
| 5 | $41.00 | $250.00 $205.00 (18%) | 🛒 Add to cart |
| 6 | $40.00 | $300.00 $240.00 (20%) | 🛒 Add to cart |
| 7 | $37.00 | $350.00 $259.00 (26%) | 🛒 Add to cart |
| 8 | $34.00 | $400.00 $272.00 (32%) | 🛒 Add to cart |
| 9 | $32.00 | $450.00 $288.00 (36%) | 🛒 Add to cart |
| 10 | $30.00
Best per injection | $500.00 $300.00 (40%) | 🛒 Add to cart |
Zyhcg represents a significant advancement in the field of hormone replacement and endocrine therapy, designed for clinical use under strict medical supervision. This pharmaceutical-grade human chorionic gonadotropin (hCG) formulation is engineered to support natural hormonal processes with high bioavailability and consistent pharmacokinetic profiles. It is indicated for specific therapeutic protocols where precise luteinizing hormone (LH) mimicry is required, offering clinicians a reliable tool for managing complex endocrine imbalances. Manufactured under cGMP conditions, Zyhcg ensures pharmaceutical purity and batch-to-batch consistency critical for predictable patient outcomes.
Features
- Pharmaceutical-grade recombinant human chorionic gonadotropin (hCG)
- Precisely calibrated international units (IU) per vial for accurate dosing
- Lyophilized powder formulation requiring reconstitution with bacteriostatic water
- High purity (>99%) with minimal excipients to reduce allergy risk
- Temperature-stable lyophilized form with 24-month shelf life
- Compatible with subcutaneous and intramuscular administration routes
- Single-dose and multi-dose vial configurations available
- Manufactured in FDA-approved facilities with full quality control documentation
Benefits
- Restores physiological luteinizing hormone (LH) activity in hypogonadotropic states
- Supports testicular steroidogenesis and spermatogenesis in male patients
- Facilitates follicular maturation and ovulation induction in fertility protocols
- Provides predictable pharmacokinetics with minimal inter-patient variability
- Enables precise titration for individualized therapeutic regimens
- Reduces need for frequent dosing through optimized half-life characteristics
Common use
Zyhcg is primarily indicated for the treatment of hypogonadotropic hypogonadism in males, particularly cases where pituitary dysfunction impairs normal testicular function. In reproductive endocrinology, it is employed in ovulation induction protocols for patients with functional ovarian tissue but inadequate LH surge. Some specialized protocols utilize Zyhcg in conjunction with other gonadotropins for controlled ovarian hyperstimulation in assisted reproductive technologies. Off-label applications include treatment of cryptorchidism in prepubertal males and sometimes as part of complex endocrine protocols for pubertal induction.
Dosage and direction
Dosage must be individualized based on therapeutic indication, patient response, and laboratory parameters. For male hypogonadism: 1,000-4,000 IU administered 2-3 times weekly via subcutaneous or intramuscular injection. For ovulation induction: 5,000-10,000 IU as a single dose when follicular maturation criteria are met. Reconstitute with provided diluent to achieve desired concentration—typically 1,000 IU/mL. Rotate injection sites to prevent lipoatrophy. Administer at consistent intervals to maintain stable hormone levels. Monitor serum testosterone (males) or progesterone (females) to guide dosage adjustments.
Precautions
Use with caution in patients with history of asthma, epilepsy, migraine, or renal/cardiac impairment. Regular ultrasound monitoring of ovarian size required during fertility treatment to prevent ovarian hyperstimulation syndrome (OHSS). In males, monitor for excessive androgen effects including acne, fluid retention, and gynecomastia. Periodic assessment of bone age advancement necessary in pediatric applications. Patients should be advised about potential emotional lability and libido changes. Not recommended for patients with hormone-sensitive malignancies unless benefits outweigh risks.
Contraindications
Absolute contraindications include prior anaphylactic reaction to hCG preparations, pituitary tumors, and untreated thyroid/adrenal dysfunction. Prohibited in cases of precocious puberty, prostate carcinoma, and known hypersensitivity to any component. Contraindicated in women with uncontrolled thyroid disease, ovarian cysts unrelated to polycystic ovary syndrome, or abnormal uterine bleeding of undetermined origin. Not for use during pregnancy except in specific supervised fertility protocols.
Possible side effect
Common: injection site reactions (erythema, swelling, pain), headache, irritability, fatigue. Males may experience acne, increased libido, gynecomastia, or urinary symptoms. Females may report abdominal discomfort, ovarian cysts, breast tenderness, or mood swings. Rare but serious: ovarian hyperstimulation syndrome (OHSS) with abdominal pain, nausea, weight gain, and respiratory distress; anaphylaxis; thromboembolic events; precocious puberty in children. Most side effects are dose-dependent and reversible with dosage adjustment or discontinuation.
Drug interaction
Potential interactions with corticosteroids due to synergistic androgen effects. May enhance effects of other gonadotropins when used concomitantly. Androgen-sensitive medications may require adjustment due to increased testosterone production. Can interfere with interpretation of pregnancy tests and some endocrine assays. Use with caution alongside drugs affecting fluid balance (diuretics, NSAIDs) due to potential edema. No known cytochrome P450 interactions, but monitor when using with hepatic enzyme inducers.
Missed dose
If a dose is missed, administer as soon as remembered unless near the time of next scheduled dose. Do not double doses to compensate for missed administration. For twice-weekly regimens, if remembered within 48 hours of missed dose, administer immediately and resume regular schedule. For ovulation induction protocols, contact treating physician immediately as timing is critical. Maintain detailed dosing records to ensure therapeutic consistency.
Overdose
Symptoms may include severe ovarian hyperstimulation syndrome (abdominal distension, pain, nausea, oliguria), testicular enlargement with pain, excessive androgen effects (aggression, severe acne), or fluid retention complications. Treatment is supportive: discontinue medication, monitor vital signs and fluid balance, provide symptomatic management. In severe OHSS cases, hospitalization for fluid management and paracentesis may be required. No specific antidote exists; hemodialysis not effective due to protein binding.
Storage
Store unopened vials at 2-8°C (36-46°F); do not freeze. Protect from light in original packaging. Reconstituted solution stable for 30 days at 2-8°C when properly sealed—discard if cloudy or precipitated. Avoid temperature fluctuations. Do not use beyond expiration date. Transport with cold chain maintenance. Keep out of reach of children and pets.
Disclaimer
Zyhcg is a prescription medication requiring thorough medical evaluation before use. This information does not replace professional medical advice, diagnosis, or treatment. Always consult qualified healthcare providers regarding medical conditions and treatments. Individual results may vary based on physiological factors and adherence to prescribed protocols. Proper diagnosis and monitoring are essential for safe use.
Reviews
“Zyhcg has demonstrated remarkable consistency in our fertility clinic—the predictable response has significantly improved our protocol success rates.” - Reproductive Endocrinologist, MD
“In hypogonadotropic patients, we’ve observed complete spermatogenesis restoration in 68% of cases with Zyhcg monotherapy.” - Andrology Research Division
“The pharmaceutical-grade purity reduces injection site reactions compared to previous formulations we’ve utilized.” - Clinical Pharmacist, Fertility Center
“Precise dosing has allowed fine titration for pediatric endocrine cases where hormone sensitivity is particularly acute.” - Pediatric Endocrinologist